Skip to main content

Table 10 Assessment of ability to detect change of NVSA© scores with the sPGA and effect size

From: Development and psychometric validation of the Nausea/Vomiting Symptom Assessment patient-reported outcome (PRO) instrument for adults with secondary hyperparathyroidism

  

Number of days of vomiting or Nausea

Number of vomiting episodes

Mean severity of Nausea

sPGA Week

sPGA

N

Difference in means

Effect Size

N

Difference in means

Effect size

N

Difference in means

Effect size

(Week 2 – Week 1)

No Change

41

0.19 (0.98)

0.08

42

0.51 (2.49)

0.29

41

0.21 (0.93)

0.17

(Week 3 – Week 2)

No Change

44

−0.10 (0.97)

0.04

47

−0.01 (1.43)

0.00

44

−0.05 (0.74)

0.04

(Week 4 – Week 3)

No Change

52

0.15 (1.10)

0.06

   

52

−0.01 (0.50)

0.01

(Week 5 – Week 4)

No Change

47

−0.00 (0.95)

0.00

49

−0.13 (1.18)

0.06

47

−0.04 (0.35)

0.04

(Week 6 – Week 5)

No Change

45

0.07 (1.13)

0.03

53

0.26 (1.24)

0.17

45

0.03 (0.40)

0.03

(Week 7 – Week 6)

No Change

44

−0.01 (0.77)

0.00

47

−0.15 (0.75)

0.07

44

−0.04 (0.30)

0.03

(Week 8 – Week 7)

No Change

47

−0.13 (1.09)

0.05

49

−0.14 (0.77)

0.08

47

−0.12 (0.38)

0.12

(Week 2 – Week 1)

Any Improvement

7

−1.80 (2.43)

0.73

   

7

−1.02 (1.24)

0.82

(Week 3 – Week 2)

Any Improvement

9

−0.47 (2.37)

0.20

8

−3.77 (8.21)

0.97

9

−0.74 (1.11)

0.53

(Week 4 – Week 3)

Any Improvement

7

−1.06 (1.16)

0.45

   

7

−0.21 (0.39)

0.22

(Week 5 – Week 4)

Any Improvement

7

−1.26 (2.56)

0.54

6

−1.67 (2.73)

0.79

7

−0.26 (1.65)

0.25

(Week 6 – Week 5)

Any Improvement

7

0.17 (2.52)

0.07

   

7

−0.26 (0.69)

0.23

(Week 7 – Week 6)

Any Improvement

10

−0.67 (1.56)

0.27

8

−2.06 (2.76)

0.97

10

−0.62 (1.46)

0.49

(Week 8 – Week 7)

Any Improvement

7

−1.05 (1.30)

0.42

7

−1.07 (6.47)

0.60

7

−0.29 (0.48)

0.29

(Week 2 – Week 1)

Any Worsening

10

0.55 (1.99)

0.22

11

2.40 (7.44)

1.37

10

0.54 (1.05)

0.44

(Week 3 – Week 2)

Any Worsening

9

0.56 (1.99)

0.24

7

−0.99 (4.63)

0.26

9

− 0.22 (1.85)

0.16

(Week 4 – Week 3)

Any Worsening

         

(Week 5 – Week 4)

Any Worsening

6

1.83 (1.72)

0.78

   

6

0.76 (0.78)

0.73

(Week 6 – Week 5)

Any Worsening

11

0.70 (1.56

0.28

6

1.42 (2.25)

0.95

11

0.40 (0.56)

0.36

(Week 7 – Week 6)

Any Worsening

8

0.33 (1.55)

0.13

7

2.00 (2.58)

0.94

8

0.51 (0.72)

0.41

(Week 8 – Week 7)

Any Worsening

6

−0.05 (0.88)

0.02

   

6

−0.06 (1.13)

0.06

  1. Empty rows = sample size < n = 6 and analyses not conducted. The within-patient effect size was defined as the within-patient change score (post-pre score) divided by pre (group) standard deviation